Should you buy Anthera Pharmaceuticals stock? (Other OTC:ANTH). Let's see how it does in our automated value investing analysis system.
Advantages | Disadvantages | Neutral |
---|---|---|
|
|
|
ANTH Price (Anthera Pharmaceuticals stock price per share) |
$0.00 | |
PE Ratio versus Sector | 100% lower than other Healthcare stocks | |
PE Ratio versus Industry | 57.8% higher than other Biotechnology stocks | |
Cash Yield | -500161.86% | |
Free Cash Flow Jitter | 74% |
Based on our analysis, we believe that you should not buy Anthera Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Does Anthera Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles
How Does Social Distancing Affect the Economy?
How Does Portfolio Churning Affect Your Returns?
What are The Dow, S&P 500, and NASDAQ Indexes?
How to Invest $1000 in the Stock Market